Insight Molecular Diagnostics (IMDX) Interest Expenses (2015 - 2026)

Insight Molecular Diagnostics has reported Interest Expenses for 12 years, with the latest figure at $2.2 million in Q1 2026.

• Quarterly Interest Expenses rose 110.85% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (up 110.85% YoY) and the FY2025 annual result came in at $8.5 million, down 86.75% from the prior year.
• Interest Expenses grew to $2.2 million in Q1 2026 per IMDX's latest filing, from $329000.0 in the prior quarter.
• Over five years, Interest Expenses peaked at $3.8 million in Q1 2022 and troughed at $31000.0 in Q3 2023.
• A 5-year average of $1.4 million and a median of $696000.0 in 2024 frame the typical range for Interest Expenses.
• The sharpest annual moves came in 2023 and 2024: Interest Expenses tumbled 99.19% in 2023, then jumped 10545.16% in 2024.
• Over 5 years, Interest Expenses stood at $289000.0 in 2022, then dropped by 11.76% to $255000.0 in 2023, then rose by 9.41% to $279000.0 in 2024, then rose by 17.92% to $329000.0 in 2025, then jumped by 555.62% to $2.2 million in 2026.
• According to Business Quant data, Interest Expenses over the past three periods registered $2.2 million, $329000.0, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.